Adenosine A2A-cannabinoid CB1 receptor interaction: An integrative mechanism in striatal glutamatergic neurotransmission

Brain Research

Volumn 1476, Issue , 2012, Pages 108-118

  Tebano, Maria Teresa ^a   Martire, Alberto ^a   Popoli, Patrizia ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

A2A adenosine receptor; CB1 cannabinoid receptor; Glutamate release; Heteromer; Striatum

Indexed keywords

ADENOSINE A2A RECEPTOR; CANNABINOID 1 RECEPTOR; DOPAMINE 2 RECEPTOR; METABOTROPIC RECEPTOR 5;

BASAL GANGLION; ELECTRIC POTENTIAL; EXTRACELLULAR FIELD POTENTIAL; GLIA CELL; GLUTAMATERGIC NEUROTRANSMISSION; HUMAN; INHIBITION KINETICS; MOLECULAR INTERACTION; NERVE CELL; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PHYSIOLOGY; PRESYNAPTIC NERVE; PRIORITY JOURNAL; REVIEW; STRIATE CORTEX; SYNAPSE;

ANIMALS; CANNABINOID RECEPTOR MODULATORS; CORPUS STRIATUM; GLUTAMIC ACID; PURINERGIC AGENTS; RECEPTOR, ADENOSINE A2A; RECEPTOR, CANNABINOID, CB1; SYNAPTIC TRANSMISSION;

EID: 84866933069     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.04.051     Document Type: Review

References (130)

1. L.F. Agnati, D. Guidolin, G. Leo, C. Carone, S. Genedani, and K. Fuxe Receptor-receptor interactions: a novel concept in brain integration Prog. Neurobiol. 90 2010 157 175
2. O. Aizman, H. Brismar, P. Uhlén, E. Zettergren, A.I. Levey, H. Forssberg, P. Greengard, and A. Aperia Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons Nat. Neurosci. 3 2000 226 230
3. R.L. Albin, A.B. Young, and J.B. Penney The functional anatomy of basal ganglia disorders Trends Neurosci. 12 1989 366 375
4. G.E. Alexander, and M.D. Crutcher Functional architecture of basal ganglia circuits: neural substrates of parallel processing Trends Neurosci. 13 1990 266 271
5. B.E. Alger Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids Prog. Neurobiol. 68 2002 247 286
6. M. Andersson, A. Usiello, A. Borgkvist, L. Pozzi, C. Dominguez, A.A. Fienberg, P. Svenningsson, B.B. Fredholm, E. Borrelli, P. Greengard, and G. Fisone Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons J. Neurosci. 25 2005 8432 8438
7. 2A-D2 receptor heteromerization Neuropsychopharmacology 34 2009 972 986
8. 2A receptors in the nucleus accumbens mediate locomotor depression Brain Res. Bull. 31 1993 397 404
9. D. Belin, S. Jonkman, A. Dickinson, T.W. Robbins, and B.J. Everitt Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction Behav. Brain Res. 199 2009 89 102
10. T. Bisogno, F. Berrendero, G. Ambrosino, M. Cebeira, J.A. Ramos, J. Fernandez-Ruiz, and V. Di Marzo Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function Biochem. Biophys. Res. Commun. 256 1999 377 380
11. J.P. Bolam, J.J. Hanley, P.A. Booth, and M.D. Bevan Synaptic organization of the basal ganglia J. Anat. 196 2000 527 542
12. A. Borgkvist, D. Marcellino, K. Fuxe, P. Greengard, and G. Fisone Regulation of DARPP-32 phosphorylation by D9-tetrahydrocannabinol Neuropharmacology 54 2008 31 35
13. 2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes Glia 43 2003 190 194
14. 2A receptors form higher-order oligomers in living cells J. Neurochem. 109 2009 1497 1507
15. P. Calabresi, D. Centonze, A. Pisani, and G. Bernardi Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses J. Neurosci. 17 1997 4509 4516
16. P. Calabresi, D. Centonze, P. Gubellini, G.A. Marfia, A. Pisani, G. Sancesario, and G. Bernardi Synaptic transmission in the striatum: from plasticity to neurodegeneration Prog. Neurobiol. 61 2000 231 265
17. 1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids Neuropsychopharmacology 32 2007 2249 2259
18. P. Carriba, G. Navarro, F. Ciruela, S. Ferré, V. Casado, L.F. Agnati, A. Cortes, J. Mallol, K. Fuxe, E.I. Canela, C. Lluis, and R. Franco Detection of heteromerization of more than two proteins by sequential BRET-FRET Nat. Methods 5 2008 727 733
19. D. Centonze, N. Battista, S. Rossi, N.B. Mercuri, A. Finazzi-Agrò, G. Bernardi, P. Calabresi, and M. Maccarrone A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal GABAergic transmission Neuropsychopharmacology 29 2004 1488 1497
20. D. Centonze, S. Rossi, C. Prosperetti, A. Tscherter, G. Bernardi, M. Maccarrone, and P. Calabresi Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice Biol. Psychiatry 57 2005 1583 1589
21. J.F. Chen, P.K. Sonsalla, F. Pedata, A. Melani, M.R. Domenici, P. Popoli, J. Jeiger, L.V. Lopes, and A. de Mendonça Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and fine tuning modulation Prog. Neurobiol. 83 2007 310 331
22. V. Chevaleyre, K.A. Takahashi, and P.E. Castillo Endocannabinoid mediated synaptic plasticity in the CNS Annu. Rev. Neurosci. 29 2006 37 76
23. S.R. Childers Activation of G-proteins in brain by endogenous and exogenous cannabinoids AAPS J. 8 2006 E112 E117
24. V. Chiodi, M. Uchigashima, S. Beggiato, A. Ferrante, M. Armida, A. Martire, R.L. Potenza, L. Ferraro, S. Tanganelli, M. Watanabe, M.R. Domenici, and P. Popoli Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease Neurobiol. Dis. 45 2012 983 991
25. F. Ciruela, V. Casadó, R.J. Rodrigues, R. Luján, J. Burgueño, M. Canals, J. Borycz, N. Rebola, S.R. Goldberg, J. Mallol, A. Cortés, E.I. Canela, J.F. López-Giménez, G. Milligan, C. Lluis, R.A. Cunha, S. Ferré, and R. Franco Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers J. Neurosci. 26 2006 2080 2087
26. F. Ciruela, M. Gómez-Soler, D. Guidolin, D.O. Borroto-Escuela, L.F. Agnati, K. Fuxe, and V. Fernández-Dueñas Adenosine receptor containing oligomers: their role in the control of dopamine and glutamate neurotransmission in the brain Biochim. Biophys. Acta 1808 2011 1245 1255
27. D.E. Comings Clinical and molecular genetics of ADHD and Tourette syndrome. Two related poly-genic disorders Ann. N. Y. Acad. Sci. 931 2001 50 83
28. R.A. Cunha Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors Neurochem. Int. 38 2001 107 125
29. 2A receptor blockade Purinergic Signal. 1 2005 111 134
30. 2A receptors in the rat hippocampus Brain Res. 649 1994 208 216
31. 2A receptors Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol. 353 1996 261 271
32. M.R. DeLong, and T. Wichmann Circuits and circuit disorders of the basal ganglia Arch. Neurol. 64 2007 20 24
33. M.A. Diana, and A. Marty Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE) Br. J. Pharmacol. 142 2004 9 19
34. J. Doherty, and R. Dingledine Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system Curr. Opin. Pharmacol. 3 2003 46 53
35. 2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum J. Neurochem. 90 2004 1276 1279
36. 1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling Neuroscience 119 2003 481 496
37. J. Fernández-Ruiz The endocannabinoid system as a target for the treatment of motor dysfunction Br. J. Pharmacol. 156 2009 1029 1040
38. 2A receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes Proc. Natl. Acad. Sci. U. S. A. 88 1991 7238 7241
39. S. Ferré, B.B. Fredholm, M. Morelli, P. Popoli, and K. Fuxe Adenosine dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia Trends Neurosci. 20 1997 482 487
40. S. Ferré, L.F. Agnati, F. Ciruela, C. Lluis, A.S. Woods, K. Fuxe, and R. Franco Neurotransmitter receptor heteromers and their integrative role in local modules: the striatal spine module Brain Res. Rev. 55 2007 55 67
41. S. Ferré, F. Ciruela, A.S. Woods, C. Lluis, and R. Franco Functional relevance of neurotransmitter receptor heteromers in the central nervous system Trends Neurosci. 30 2007 440 446
42. S. Ferré, F. Ciruela, C. Quiroz, R. Luján, P. Popoli, R.A. Cunha, L.F. Agnati, K. Fuxe, A.S. Woods, C. Lluis, and R. Franco Adenosine receptor heteromers and their integrative role in striatal function ScientificWorldJournal 7 2007 74 85
43. 2A-dopamine D2 receptor interactions. Implications for the function of G protein-coupled receptors Curr. Pharm. Des. 14 2008 1468 1474
44. S. Ferré, S.R. Goldberg, C. Lluis, and R. Franco Looking for the role of cannabinoid receptor heteromers in striatal function Neuropharmacology 56 Suppl. 1 2009 226 234
45. 2A receptor heteromers as key players in striatal function Front. Neuroanat. 5 2011 1 8
46. B.B. Fredholm, A.P. Ijzerman, K.A. Jacobson, K.N. Klotz, and J. Linden International Union of Pharmacology XXV. Nomenclature and classification of adenosine receptors Pharmacol. Rev. 53 2001 527 552
47. B.B. Fredholm, J.F. Chen, R.A. Cunha, P. Svenningsson, and J.M. Vaugeois Adenosine and brain function Int. Rev. Neurobiol. 63 2005 191 270
48. T.F. Freund, I. Katona, and D. Piomelli Role of endogenous cannabinoids in synaptic signalling Physiol. Rev. 83 2003 1017 1066
49. 1 receptor in rat striatal neurons: a confocal microscopy study Synapse 53 2004 159 167
50. K. Fuxe, S. Ferré, S. Genedani, R. Franco, and L.F. Agnati Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function Physiol. Behav. 92 2007 210 217
51. K. Fuxe, D. Marcellino, G. Leo, and L.F. Agnati Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis Curr. Opin. Pharmacol. 10 2010 14 22
52. G.L. Gerdeman, and J. Fernández-Ruiz The endocannabinoid system in the physiology and pathology of the basal ganglia A. Köfalvi, Cannabinoids and the Brain 2008 Springer US 423 484
53. G.L. Gerdeman, and D.M. Lovinger Cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum J. Physiol. 85 2001 468 471
54. G.L. Gerdeman, J. Ronesi, and D.M. Lovinger Postsynaptic endocannabinoid release is critical to long term depression in the striatum Nat. Neurosci. 5 2002 446 451
55. C.R. Gerfen Basal ganglia G. Paxinos, The Rat Nervous System 2004 Elsevier Academic Press Amsterdam 445 508
56. A. Giuffrida, L.H. Parsons, T.M. Kerr, F. Rodríguez de Fonseca, M. Navarro, and D. Piomelli Dopamine activation of endogenous cannabinoid signaling in dorsal striatum Nat. Neurosci. 2 1999 358 363
57. A. Graybiel Neurotransmitters and neuromodulators in the basal ganglia Trends Neurosci. 13 1990 244 254
58. A.M. Graybiel, T. Aosaki, A.W. Flaherty, and M. Kimura The basal ganglia and adaptive motor control Science 265 1994 1826 1831
59. Y. Hashimotodani, T. Ohno-Shosaku, and M. Kano Endocannabinoids and synaptic function in the CNS Neuroscientist 13 2007 127 137
60. 2A receptors in the nucleus accumbens and the caudate-putamen Eur. J. Pharmacol. 323 1997 127 131
61. 2A receptors in the caudate-putamen Neuroreport 9 1998 1803 1806
62. M. Herkenham, A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Cannabinoid receptor localization in brain Proc. Natl. Acad. Sci. U. S. A. 87 1990 1932 1936
63. M. Herkenham, A.B. Lynn, B.R. de Costa, and E.K. Richfield Neuronal localization of cannabinoid receptors in the basal ganglia of the rat Brain Res. 547 1991 267 274
64. 1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors J. Neurosci. 30 2010 545 555
65. 1 receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study Synapse 37 2000 71 80
66. C.C. Huang, S.W. Lo, and K.S. Hsu Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons J. Physiol. 532 2001 731 748
67. 2A, but not A1, receptors mediate the arousal effect of caffeine Nat. Neurosci. 8 2005 858 859
68. K.A. Jacobson, and Z.G. Gao Adenosine receptors as therapeutic targets Nat. Rev. Drug Discov. 5 2006 247 261
69. 2A receptor antagonist Addict. Biol. 16 2011 405 415
70. Y. Kawaguchi, C.J. Wilson, S.J. Augood, and P.C. Emson Striatal interneurons: chemical, physiological, and morphological characterization Trends Neurosci. 18 1995 527 535
71. 1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol. Pharm. 67 2005 1697 1704
72. M.S. Keshavan, R. Tandon, N.N. Boutros, and H.A. Nasrallah Schizophrenia, just the facts: what we know in 2008 part 3: neurobiology Schizophr. Res. 106 2008 89 107
73. A. Köfalvi, R.J. Rodrigues, C. Ledent, K. Mackie, E.S. Vizi, R.A. Cunha, and B. Sperlágh Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis J. Neurosci. 25 2005 2874 2884
74. R. Kotter Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum Prog. Neurobiol. 44 1994 163 196
75. A.C. Kreitzer, and R.C. Malenka Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models Nature 445 2007 643 647
76. A.C. Kreitzer, and R.C. Malenka Striatal plasticity and basal ganglia circuit function Neuron 60 2008 543 544
77. 2A receptor Nature 388 1997 674 678
78. 1 receptor knockout mice Science 283 1999 401 404
79. T.N. Lerner, and A.C. Kreitzer RGS4 is required for dopaminergic control of striatal LTD and susceptibility to Parkinsonian motor deficits Neuron 73 2012 347 359
80. 2A antagonists J. Neurosci. 30 2010 2160 2164
81. D.M. Lovinger Neurotransmitter role in synaptic modulation, plasticity and learning in the dorsal striatum Neuropsychopharmacology 58 2010 951 961
82. D.M. Lovinger, J.G. Partridge, and K.C. Tang Plastic control of striatal glutamatergic transmission by ensemble actions of several neurotransmitters and targets for drugs of abuse Ann. N. Y. Acad. Sci. 1003 2003 226 240
83. D.M. Lovinger, M.I. Davis, and R.M. Costa Endocannabinoid signaling in the striatum H. Steiner, K.Y. Tseng, Handbook of Basal Ganglia Structure and Function 2009 Elsevier 167 175
84. T. Manabe, D.J. Wyllie, D.J. Perkel, and R.A. Nicoll Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus J. Neurophysiol. 70 1993 1451 1459
85. 1/D2 heteromers. A combined neurochemical and behavioral analysis Neuropharmacology 54 2008 815 823
86. 1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors Neuropsychopharmacology 33 2008 1667 1679
87. 1 receptor-mediated inhibition of striatal glutamatergic neurotransmission J. Neurochem. 116 2011 273 280
88. F. Mátyás, Y. Yanovsky, K. Mackie, W. Kelsch, U. Misgeld, and T.F. Freund Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia Neuroscience 137 2006 337 361
89. 2A receptors: an overview Brain Res. Rev. 31 1999 65 82
90. G. Navarro, S. Ferré, A. Cordomi, E. Moreno, J. Mallol, V. Casadó, A. Cortés, H. Hoffmann, J. Ortiz, E.I. Canela, C. Lluís, L. Pardo, R. Franco, and A.S. Woods Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers J. Biol. Chem. 285 2010 27346 27359
91. M.L. Perreault, A. Hasbi, M. Alijaniaram, T. Fan, G. Varghese, P.J. Fletcher, P. Seeman, B.F. O'Dowd, and S.R. George The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia J. Biol. Chem. 285 2010 36625 36634
92. M.L. Perreault, T. Fan, M. Alijaniaram, B.F. O'Dowd, and S.R. George Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2 PLoS One 7 3 2012 e33348 (Epub 2012 Mar 12)
93. 1) and mu-opioid receptors in rat nucleus accumbens Neuroscience 127 2004 101 112
94. 1) receptors in rat nucleus accumbens J. Comp. Neurol. 495 2006 299 313
95. D. Piomelli The molecular logic of endocannabinoid signalling Nat. Rev. Neurosci. 4 2003 873 884
96. 2A receptor stimulation enhances striatal extracellular glutamate levels in rats Eur. J. Pharmacol. 287 1995 215 217
97. 2A receptors Neurology 61 2003 S69 S71
98. 2A receptors in Huntington's disease Prog. Neurobiol. 81 2007 331 348
99. 2A receptors in cortical neurotransmission to the striatal direct pathway ScientificWorldJournal 9 2009 1321 1344
100. J.A. Ribeiro, and A.M. Sebastião Modulation and metamodulation of synapses by adenosine Acta Physiol. 199 2010 161 169
101. 2A and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum J. Neurochem. 92 2005 433 441
102. 1 cannabinoid receptor in mu-opioid receptor patches of the rat caudate-putamen nucleus J. Neurosci. 21 2001 823 833
103. 2A receptors in the rat central nervous system J. Comp. Neurol. 401 1998 163 186
104. 2A receptors in brain: morphological substrates for integration of striatal function Neurology 61 2003 S12 S18
105. M.C. Sañudo-Peña, K. Tsou, and J.M. Walker Motor actions of cannabinoids in the basal ganglia output nuclei Life Sci. 65 1999 703 713
106. 2A receptors and basal ganglia physiology Prog. Neurobiol. 83 2007 277 292
107. P.E. Schulz, E.P. Cook, and D. Johnston Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation J. Neurosci. 14 1994 5325 5337
108. 2A adenosine receptors in the rat hippocampus Neurosci. Lett. 138 1992 41 44
109. A.M. Sebastião, and J.A. Ribeiro Fine tuning neuromodulation by adenosine Trends Pharmacol. Sci. 21 2000 341 346
110. A.M. Sebastião, and J.A. Ribeiro Tuning and fine-tuning of synapses with adenosine Curr. Neuropharmacol. 7 2009 180 194
111. 2A receptor knock-outs J. Neurosci. 28 2008 2970 2975
112. 2A receptors in rats Neurosci. Lett. 352 2003 167 170
113. 2A receptors on synaptic connections of spiny projection neurons in the neostriatal inhibitory network J. Neurophysiol. 99 2008 1884 1889
114. 2A receptors are involved in physical dependence and place conditioning induced by THC Eur. J. Neurosci. 20 2004 2203 2213
115. 1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of D9-tetrahydrocannabinol on spatial memory Neuropsychopharmacology 36 2011 472 487
116. 2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum Eur. J. Neurosci. 12 2000 4033 4037
117. 2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens Neuroscience 79 1997 753 764
118. M.T. Tebano, A. Pintor, C. Frank, M.R. Domenici, A. Martire, R. Pepponi, R.L. Potenza, R. Grieco, and P. Popoli Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum J. Neurosci. Res. 77 2004 100 1077
119. 1 receptors in the rodent striatum J. Neurochem. 110 2009 1921 1930
120. J.M. Tepper, and J.P. Bolam Functional diversity and specificity of neostriatal interneurons Curr. Opin. Neurobiol. 14 2004 685 692
121. J.M. Tepper, T. Koós, and C.J. Wilson GABAergic microcircuits in the neostriatum Trends Neurosci. 27 2004 662 669
122. J.M. Tepper, E.D. Abercrombie, and J.P. Bolam Basal ganglia microcircuits Prog. Brain Res. 160 2007 3 7
123. 2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission Neuropharmacology 53 2007 783 789
124. 2A receptor interaction in the striatum: implications for Parkinson's disease J. Neurosci. 31 2011 1850 1862
125. 1 receptors in the rat central nervous system Neuroscience 83 1998 393 411
126. M. Uchigashima, M. Narushima, M. Fukaya, I. Katona, M. Kano, and M. Watanabe Subcellular arrangement of molecules for 2-arachidonoyl-glycerol- mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum J. Neurosci. 27 2007 3663 3676
127. M. van der Stelt, and V. Di Marzo The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders Eur. J. Pharmacol. 480 2003 133 150
128. T. Wichmann, and M.R. DeLong Functional neuroanatomy of the basal ganglia Parkinson's disease Adv. Neurol. 91 2003 9 18
129. R. Wilson, and R. Nicoll Endocannabinoid signalling in the brain Science 296 2002 678 682
130. 1 receptors and eliminates heroin seeking behavior in addicted rats Proc. Natl. Acad. Sci. U. S. A. 103 2006 7877 7882